Sophie A. Chrisomalis

Sophie Chrisomalis practices at Mount Sinai - Brooklyn in Brooklyn, New York.

Sophie Chrisomalis' NPI, 1417323882, was assigned on August 19, 2015. Sophie Chrisomalis holds New York license 289886.

Sophie Chrisomalis' primary practice is Mount Sinai - Brooklyn, at 3201 Kings Hwy, Brooklyn, NY 11234 in Kings County. The practice phone is (646) 605-6009.

Sophie Chrisomalis' primary practice is Mount Sinai - Brooklyn in Brooklyn, New York. Sophie Chrisomalis is also affiliated with Mount Sinai Beth Israel. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Sophie Chrisomalis to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sophie Chrisomalis practices. Vendor and product names are available with a free account.

Internal medicine is Sophie Chrisomalis' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sophie Chrisomalis is licensed in New York.

CMS data shows 86 Medicare services from Sophie Chrisomalis across 1 procedure code in 2024, all of them office visits, for 64 Medicare patients. Medicare paid $6,406 for them. Every service was in an office.

CMS counts 64 Medicare patients who saw Sophie Chrisomalis in 2024. The largest group is 65 to 74, with 32 patients. 69% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sophie Chrisomalis' median patient age at 44, with 72% women.

In 2024, Sophie Chrisomalis wrote 364 Medicare Part D claims for 67 patients. 88% of them were for generic drugs. CMS names the drug for 161 of them, across 8 drugs with 11 or more claims each, at $2,550 in total drug cost. In 2023, CMS named 312 claims across 13 drugs.

Sophie Chrisomalis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sophie Chrisomalis as offering telehealth.

CMS Open Payments shows 2 general payments to Sophie Chrisomalis from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $84.